Sorry, you need to enable JavaScript to visit this website.

About INVEGA SUSTENNA® (paliperidone palmitate) Skip to main content

About INVEGA SUSTENNA® (paliperidone palmitate)

Finding a medicine that works to control your symptoms of schizoaffective disorder is key to your treatment plan. It’s good to know there is an option for how—and how often—you take your medicine. Unlike daily pills, INVEGA SUSTENNA® is given differently.

A long-acting, once-monthly* medicine

INVEGA SUSTENNA® is a medication given by an injection monthly by your doctor—or another healthcare professional on your Treatment Team—in the arm or buttocks.

After starting doses.

Why a once-monthly medicine?

While no medication can guarantee that you won’t miss a dose, you’ll know that once you’ve received your injection of INVEGA SUSTENNA®, the medicine is in your system and being gradually released over 4 weeks.

It also means you’ll have one less pill to think about taking every day.

One medicine for multiple symptoms

Schizoaffective disorder has symptoms of both schizophrenia and a mood disorder. INVEGA SUSTENNA® helps manage these symptoms. In a clinical trial, 85% of people treated with INVEGA SUSTENNA® did not have a relapse of their symptoms for 15 months.

You may experience some side effects with INVEGA SUSTENNA®. Not all people experience the same side effects. The most common side effects of INVEGA SUSTENNA® include: injection site reactions; sleepiness or drowsiness; dizziness; feeling of inner restlessness or needing to be constantly moving; abnormal muscle movements, including tremor (shaking), shuffling, uncontrolled involuntary movements, and abnormal movements of your eyes. Please see the important safety information below and speak with you healthcare professional.

Approved for the treatment of schizophrenia and schizoaffective disorder. ✱✱ Please discuss your symptoms with your healthcare professional. He or she will review your symptoms and may consult the established guidelines, which are available in the Diagnostic and Statistical Manual of Mental Disorders, where applicable.